|
|
Volumn 28, Issue 3, 1999, Pages 643-676
|
|
Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: Protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
AMPRENAVIR;
ANTIRETROVIRUS AGENT;
DELAVIRDINE;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
ZALCITABINE;
ZIDOVUDINE;
CLINICAL TRIAL;
DRUG EFFICACY;
HELPER CELL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
META ANALYSIS;
PATIENT CODING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
TREATMENT INDICATION;
VIRUS LOAD;
|
|
EID: 0033014605
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/515179 Document Type: Review |
|
Times cited : (45)
|
|
References (99)
|
